LENZ Therapeutics (LENZ) vs Vivani Medical (VANI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Vivani Medical (VANI) has outperformed LENZ Therapeutics (LENZ) over the past year, losing 11.3% versus a loss of 92.1%. Over five years, VANI leads with a -85.7% price change compared with -95.9% for LENZ. LENZ Therapeutics is the larger company by market cap ($114.5 million vs $112.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LENZ | VANI |
|---|---|---|
| Share price | $3.65 | $1.25 |
| Market cap | $114.53M | $112.75M |
| 1-day change | +3.26% | +1.63% |
| YTD return | -77.22% | +1.63% |
| 1-year return | -92.12% | -11.35% |
| 5-year return | -95.93% | -85.73% |
| EPS (TTM) | $-4.26 | $-0.36 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $46.75 | $1.92 |
| 52-week low | $3.35 | $0.923 |
| Distance from 52-week high | -92.20% | -34.90% |
| Analyst consensus | none | none |
| Avg. price target upside | +558.44% | +206.40% |
| Average volume | 833.64K | 228.48K |
| Shares outstanding | 31.42M | 90.20M |
| Employees | 152 | 42 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- VANI has outperformed LENZ by 80.8 percentage points over the past year.
About LENZ Therapeutics
LENZ stock →LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 152 employees
About Vivani Medical
VANI stock →Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 42 employees
LENZ vs VANI FAQ
Which is bigger, LENZ Therapeutics or Vivani Medical?
LENZ Therapeutics (LENZ) is larger, with a market capitalization of $114.53M compared with $112.75M for Vivani Medical (VANI).
Which stock has performed better over the past year, LENZ or VANI?
VANI returned -11.35% over the past 12 months, compared with -92.12% for LENZ (price return, excluding dividends). Past performance does not predict future results.
Are LENZ Therapeutics and Vivani Medical in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Biological Products (No Diagnostic Substances) for LENZ Therapeutics and Biotechnology: Electromedical & Electrotherapeutic Apparatus for Vivani Medical.